VASOPRESSOR COMPONENTS OF PHEOCHROMOCYTOMAS

Abstract

Article1 July 1951VASOPRESSOR COMPONENTS OF PHEOCHROMOCYTOMASKARL H. BEYER, Ph.D., M.D., F.A.C.P., CHARLES A. ROSS, M.S., VIRGIL D. WIEBELHAUS, Ph.D., WILLIAM S. WALLER, B.S., GRACE S. SCHUCHARDT, B.S.KARL H. BEYER, Ph.D., M.D., F.A.C.P.Search for more papers by this author, CHARLES A. ROSS, M.S.Search for more papers by this author, VIRGIL D. WIEBELHAUS, Ph.D.Search for more papers by this author, WILLIAM S. WALLER, B.S.Search for more papers by this author, GRACE S. SCHUCHARDT, B.S.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-35-1-117 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptThe purpose of this report is to present analyses of the pressor amine content of two pheochromocytomas and the metabolism of the hypertensive agents in these and a third tumor. Probably none of the reports of the epinephrine content of pheochromocytomas prior to the past few months is valid, qualitatively. The lack of specificity of the bioassay or chemical methods as they were used in the past did not differentiate that hormone from related compounds having similar biologic or chemical properties. Present evidence indicates that epinephrine may not even be the predominant pressor agent in some of these tumors. The...Bibliography1a. CannonRosenblueth WBA: Studies on conditions of activity in endocrine organs; sympathin E and sympathin I, Am. J. Physiol. 104: 557-574, 1933. b. Cannon, W. B., and Rosenblueth, A.: Autonomic neuroeffector systems, 1937, The Macmillan Co., New York. CrossrefGoogle Scholar2a. AbelCrawford JJAC: On the blood-pressure-raising constituent of the suprarenal capsule, Bull. Johns Hopkins Hosp. 8: 151-157, 1897. b. Abel, J. J.: Ueber den blutdruckerregenden Bestandtheil der Nebenniere, das Epinephrin, Ztschr. f. physiol. Chem. 28: 318-362, 1899. Google Scholar3a. Loewi O: Quantitative und qualitative Untersuchungen über den Sympathicusstoff, Arch. f. d. ges. Physiol. 237: 504-514, 1936. b. Gaddum, J. H., and Kwiatkowski, H.: Action of ephedrine, J. Physiol. 94: 87-100, 1938. c. Gaddum, J. H., and Kwiatkowski, H.: Properties of substance liberated by adrenergic nerves in rabbit's ear, J. Physiol. 96: 385-391, 1939. d. Gaddum, J. H., and Schild, H.: A sensitive physical test for adrenaline, J. Physiol. 80: 9P, 1933. e. Gaddum, J. H., Jang, C. S., and Kwiatkowski, H.: Effect on intestine of substance liberated by adrenergic nerves in rabbit's ear, J. Physiol. 96: 104-108, 1939. CrossrefGoogle Scholar4. BargerDale GHH: Chemical structure and sympathomimetic action of amines, J. Physiol. 41: 19-59, 1910. CrossrefMedlineGoogle Scholar5. Bacq ZM: La pharmacologie du système nerveux autonome, et particulièrement du sympathique, d'après la théorie neurohumorale, Ann. de physiol. 10: 467-553, 1934. Google Scholar6a. StehleEllsworth RLHC: Dihydroxyphenyl ethanolamine (arterenol) as possible sympathetic hormone, J. Pharmacol. and Exper. Therap. 59: 114-121, 1937. b. Greer, C. M., Pinkston, J. O., Baxter, J. H., Jr., and Brannon, E. S.: Comparison of responses of smooth muscle to d1-β-(3,4-dihydroxyphenyl)-β-hydroxy-ethylamine (arterenol), 1-epinephrine, and "liver sympathin." I. Responses of smooth muscle of iris and of vascular smooth muscle, J. Pharmacol. and Exper. Therap. 60: 108-109, 1937. c. Greer, C. M., Pinkston, J. O., Baxter, J. H., Jr., and Brannon, E. S.: Nor-epinephrine (β-(3,4-dihydroxyphenyl)-β-hydroxyethylamine) as possible mediator in sympathetic division of autonomic nervous system, J. Pharmacol. and Exper. Therap. 62: 189-227, 1938. Google Scholar7a. GaddumGoodwin JHLG: Experiments on liver sympathin, J. Physiol. 105: 357-369, 1947. b. von Euler, U. S.: Presence of sympathomimetic substance in extracts of mammalian heart, J. Physiol. 105: 38-44, 1946. c. von Euler, U. S.: Presence of substance with sympathin E properties in spleen extracts, Acta physiol. Scandinav. 11: 168-186, 1946. d. von Euler, U. S.: Specific sympathomimetic ergone in adrenergic nerve fibres (sympathin) and its relations to adrenaline and nor-adrenaline, Acta physiol. Scandinav. 12: 73-97, 1946. e. von Euler, U. S.: Identification of the sympathomimetic ergone in adrenergic nerves of cattle (sympathin N) with laevo-noradrenaline, Acta physiol. Scandinav. 16: 63-74, 1948. f. von Euler, U. S., and Schmiterlöw, C. G.: Sympathomimetic activity in extracts of normal human and bovine blood, Acta physiol. Scandinav. 13: 1-8, 1947. g. von Euler, U. S., and Åström, A.: Liberation of histamine and sympathin by stimulation of isolated splenic nerves from cattle, Acta physiol. Scandinav. 16: 97-104, 1948. h. Dawes, G. S.: Amidines, guanidines, and adrenaline inactivation in liver, Brit. J. Pharmacol. 1: 21-37, 1946. i. West, G. B.: Injection of adrenaline and noradrenaline and further studies on liver sympathin, Brit. J. Pharmacol. 3: 189-197, 1948. CrossrefGoogle Scholar8. BacqFischer ZMP: Nature de la substance sympathicomimétique extraite des nerfs ou des tissus des mammifères, Arch. internat. de physiol. 55: 73-91, 1947. MedlineGoogle Scholar9. Editorial: The sympathetic transmitter, Brit. M. J. 1: 715, 1949. CrossrefGoogle Scholar10. BülbringBurn EJH: Liberation of noradrenaline from the suprarenal gland, Brit. J. Pharmacol. 4: 202-208, 1949. Google Scholar11a. Blaschko H: The specific action of 1-dopa decarboxylase, J. Physiol. 96: 50P, 1939. b. Blaschko, H.: Activity of 1(_____)-dopa decarboxylase, J. Physiol. 101: 337-349, 1942. Google Scholar12. Beyer KH: Sympathomimetic amines; relation of structure to their action and inactivation, Physiol. Rev. 26: 169-197, 1946. CrossrefMedlineGoogle Scholar13a. Schümann HJ: Arterenol im nebennieren Mark, Klin. Wchnschr. 26: 604, 1948. b. Schümann, H. J.: Comparative studies on the effect of adrenaline, arterenol, and epinine on blood pressure, spleen contents, intestine and blood sugar, Arch. f. exper. Path. u. Pharmakol. 206: 164-170, 1949. CrossrefMedlineGoogle Scholar14. BülbringBurn EJH: Liberation of noradrenaline from adrenal medulla by splanchnic stimulation, Nature, London 163: 363, 1949. CrossrefMedlineGoogle Scholar15a. von EulerHamberg USU: 1-noradrenaline in the suprarenal medulla, Nature, London 163: 642-643, 1949. b. Goldenberg, M., Faber, M., Alston, E. J., and Chargaff, E. C.: Evidence for the occurrence of nor-epinephrine in the adrenal medulla, Science 109: 534-535, 1949. c. Tullar, B. F.: The separation of 1-arterenol from natural U.S.P. epinephrine, Science 109: 536-537, 1949. d. Auerbach, M. E., and Angell, E.: The determination of arterenol in epinephrine, Science 109: 537-538, 1949. CrossrefMedlineGoogle Scholar16a. James WO: Demonstration and separation of noradrenaline, adrenaline, and methyladrenaline, Nature, London 161: 851-852, 1948. b. Holton, P.: Noradrenaline in adrenal medullary tumours, Nature, London 163: 217, 1949. CrossrefMedlineGoogle Scholar17. du Vigneaud V: Migration of the methyl group in the body, Proc. Am. Philos. Soc. 92: 127-135, 1948. MedlineGoogle Scholar18a. Bülbring E: The methylation of noradrenaline by minced suprarenal tissue, Brit. J. Pharmacol. 4: 234-244, 1949. b. Bülbring, E., and Burn, J. H.: Formation of adrenaline from noradrenaline in the perfused suprarenal gland, Brit. J. Pharmacol. 4: 245-253, 1949. Google Scholar19. HoltzKroneberg PG: Biologische Adrenalinsynthene, Klin. Wchnschr. 26: 605, 1948. CrossrefMedlineGoogle Scholar20a. HoltzHeise PR: Fermentativer Abbau von 1-dioxyphenylalanin (dopa) durch Niere, Arch. f. exper. Path. u. Pharmakol. 191: 87-118, 1938. b. Holtz, P., and Credner, K.: Über das Vorkommen der Dopadecarboxylase im Pancreas, Arch. f. exper. Path. u. Pharmakol. 199: 145-152, 1942. c. Holtz, P., and Credner, K.: Die enzymatische Entstehung von Oxytyramin im Organismus und die physiologische Bedeutung der Dopadecarboxylase, Arch. f. exper. Path. u. Pharmakol. 200: 356-388, 1942. d. Holtz, P., Credner, K., and Strübing, C.: Dopahyperglykämie, Ztschr. f. physiol. Chem. 280: 9-15, 1944. CrossrefGoogle Scholar21. Beyer KH: Chemical factors in hypertension, Advances in Chemistry, Am. Chem. Soc. Series No. 2, pg. 37-57, 1950. Google Scholar22. GoldenbergPinesBaldwinGreeneRoh MKLEdDGCE: The hemodynamic response of man to norepinephrine and epinephrine and its relation to the problem of hypertension, Am. J. Med. 5: 792-806, 1948. CrossrefMedlineGoogle Scholar23. PitcairnYoumans DMWB: Potent pressor action of an extract of a phaeochromocytoma after adrenolytic doses of dibenamine, Federation Proc. 8: 127, 1949. Google Scholar24. MayockRose RLE: Insensitivity to epinephrine in patient with functioning tumor of adrenal medulla, Am. J. M. Sc. 213: 324-330, 1947. CrossrefMedlineGoogle Scholar25. PotterElvehjem VCA: Modified method for study of tissue oxidations, J. Biol. Chem. 114: 495-504, 1936. CrossrefGoogle Scholar26. BeyerShapiro KHSH: Excretion of conjugated epinephrine related compounds, Am. J. Physiol. 144: 321-330, 1945. CrossrefGoogle Scholar27. Lavietes PH: Anaerobic ultrafiltration, J. Biol. Chem. 120: 267-275, 1937. CrossrefGoogle Scholar28 a. Beyer K. H. : Enzymic inactivation of substituted phenylpropyl-(sympathomimetic)-amines, J. Pharmacol. and Exper. Therap. 71: 151-163, 1941. b. Beyer, K. H.: Relation of molecular configuration to rate of deamination of sympathomimetic amines by aminase, J. Pharmacol. and Exper. Therap. 79: 85-95, 1943. Google Scholar29. Beyer KH: Relation of molecular configuration to inactivation of sympathomimetic amines in presence of phenol oxidase, J. Pharmacol. and Exper. Therap. 77: 247-257, 1943. Google Scholar30a. Richter D: Inactivation of adrenaline in vivo in man, J. Physiol. 98: 361-374, 1940. b. Richter, D., and MacIntosh, F. C.: Adrenaline ester, Am. J. Physiol. 135: 1-5, 1941. CrossrefMedlineGoogle Scholar31. LuduenaAnanenkoSiegmundMiller FPEOHLC: Comparative pharmacology of the optical isomers of arterenol, J. Pharmacol. and Exper. Therap. 95: 155-170, 1949. MedlineGoogle Scholar32a. West GB: Quantitative studies of adrenaline and noradrenaline, J. Physiol. 106: 418-425, 1947. b. Gaddum, J. H., Peart, W. S., and Vogt, M.: The estimation of adrenaline and allied substances in blood, J. Physiol. 108: 467-481, 1949. CrossrefMedlineGoogle Scholar33. CroxattoCroxattoMarty RHL: Hypertensin, hydroxytyramine, and action of renal hypertensor extracts, Proc. Soc. Exper. Biol. and Med. 52: 64-67, 1943. CrossrefGoogle Scholar34. BingZuckerPerkins RJMBW: Comparison between destruction of angiotonin, hydroxytyramine and tyramine by renal extracts, Proc. Soc. Exper. Biol. and Med. 48: 372-375, 1941. CrossrefGoogle Scholar35. To be published from this laboratory. Google Scholar36. RothKvale GMWF: Tentative test for pheochromocytoma, Am. J. M. Sc. 210: 653-660, 1945. CrossrefGoogle Scholar37. GuarneriEvans VJA: Pheochromocytoma; report of case, with new diagnostic test, Am. J. Med. 4: 806-813, 1948. CrossrefMedlineGoogle Scholar38. HymanMencher AWH: Pheochromocytoma of adrenal gland, J. Urol. 49: 755-776, 1943. CrossrefGoogle Scholar39a. GoldenbergSnyderAranow MCHH: New test for hypertension due to circulating epinephrine, J. A. M. A. 135: 971-976, 1947. b. Cahill, G. F.: Pheochromocytomas, J. A. M. A. 138: 180-186, 1948. c. Cahill, G. F., and Aranow, H., Jr.: Pheochromocytoma: diagnosis and treatment, Ann. Int. Med. 31: 389-404, 1949. CrossrefMedlineGoogle Scholar40. SpearGriswold HCD: The use of Dibenamine in pheochromocytoma, New England J. Med. 239: 736-739, 1948. CrossrefMedlineGoogle Scholar41. ThornHindleSandmeyer GWJAJA: Pheochromocytoma of adrenal associated with persistent hypertension; case report, Ann. Int. Med. 21: 122-130, 1944. LinkGoogle Scholar42. LaDueMurisonPack JSPJGT: The use of tetraethylammonium bromide as a diagnostic test for pheochromocytoma, Ann. Int. Med. 29: 914-921, 1948. LinkGoogle Scholar43. Page IH: Mechanism of the vascular action of tetraethylammonium chloride, Am. J. Physiol. 158: 403-417, 1949. CrossrefMedlineGoogle Scholar44a. Haimovici H: Inhibitory effect of Dibenamine on vasoconstrictor substances, Proc. Soc. Exper. Biol. and Med. 64: 486-488, 1947. b. Youmans, W. B., and Rankin, V. M.: Effects of Dibenamine on cardiovascular actions of epinephrine, acetylcholine, pitressin and angiotonin in unanesthetized dogs, Proc. Soc. Exper. Biol. and Med. 66: 241-244, 1947. c. Nickerson, M., Bullock, F., and Nomaguchi, G. M.: Effect of Dibenamine on renal hypertension in rats, Proc. Soc. Exper. Biol. and Med. 68: 425-429, 1948. CrossrefMedlineGoogle Scholar45a. Meek WJ: Some cardiac effects of the inhalant anesthetics and the sympathomimetic amines, Harvey Lect. 36: 188-227, 1940-41. b. Orth, O. S., Leigh, M. C., Mellish, C. H., and Stutzman, J. W.: Action of sympathomimetic amines in cyclopropane, ether, and chloroform anesthesia, J. Pharmacol. and Exper. Therap. 67: 1-16, 1939. Google Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAffiliations: Glenolden, Pennsylvania*Received for publication March 24, 1950.From the Department of Pharmacology, Medical Research Division, Sharp and Dohme, Inc., Glenolden, Pennsylvania. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited byPhæOchromocytoma a report of two cases with a review of the diagnostic testsPolycythemia Secondary to PheochromocytomaHypertonieHypertoniePHÆOCHROMOCYTOMA: DIAGNOSIS AND MANAGEMENTPrimary hypertension and hypertensive disease in early childhoodPHEOCHROMOCYTOMA: THE VALUE OF CERTAIN TESTS USED ROUTINELY IN DIAGNOSIS*EDWARD S. ORGAIN, M.D., F.A.C.P.Successful Use of Regitine (Phentolamine) in the Diagnosis and Surgical Management of a Case of PheochromocytomaPHEOCHROMOCYTOMA: TWO CASE REPORTS WITH UNUSUAL REACTIONS AND A GENERAL REVIEW*CHARLIE F. WINGO, M.D., JOHN P. WILLIAMS, M.D., F.A.C.P., FRANK A. WADE, M.D.Die Keimdrüsen und ihre KrankheitenTHE DIAGNOSIS OF PHEOCHROMOCYTOMA BY DEMONSTRATION OF PRESSOR SUBSTANCES IN THE URINE AND BY RETROPERITONEAL PNEUMOGRAPHY*CLINTON G. WEIMAN, M.D., KENNETH BACK, B.S., PETER E. RUSSO, M.D., H. A. SHOEMAKER, Ph.D., STEWART WOLF, M.D., F.A.C.P.Clinical Applications of Adrenergic Blockade in Vascular Diseases With Special Reference To Dibenamine and 688a 1 July 1951Volume 35, Issue 1Page: 117-133KeywordsBioassays and physiological analysisBiologicsDrug research and developmentEpinephrineHormonesPharmacologyPheochromocytomaSpecificityUrineVasopressors ePublished: 1 December 2008 Issue Published: 1 July 1951 PDF downloadLoading ...